[Nephrotoxicity of drugs. 3].
D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects; D002395:Catecholamines / Q000009:adverse effects; D003911:Dextrans / Q000009:adverse effects; D004492:Edetic Acid / Q000009:adverse effects; D006801:Humans; D007668:Kidney / Q000187:drug effects*; D007674:Kidney Diseases / Q000139:chemically induced*; D010615:Phenacetin / Q000009:adverse effects; D010630:Phenindione / Q000009:adverse effects; D010653:Phenylbutazone / Q000009:adverse effects; D012459:Salicylates / Q000009:adverse effects
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D002395:Catecholamines; D003911:Dextrans; D012459:Salicylates; D010630:Phenindione; D004492:Edetic Acid; D010615:Phenacetin; D010653:Phenylbutazone
La néphrotoxicité des médicaments. 3.